🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Effect of Standardizing Procedures for SC Injections of LMWH on Patients With CVD

RecruitingNAAges 18 Years - anyAllThe Hong Kong Polytechnic University
NCT06776159 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Improper subcutaneous administration of LMWH may cause complications at the injection site. Standardized protocol for subcutaneous LMWH injections in patient with cardiovascular diseases is warranted to ensure consistent best practices in clinical settings.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * patients who are in cardiac care units suffering from cardiovascular diseases prescribed with LMWH injections two times per day * Chinese Exclusion Criteria: * cognitively impaired * unconscious * refuse to participate
💊

What it tests

  • Active Control
  • Standardized injection protocol
📍

Where

1 site
Hospital Authority, Hong Kong
Hong Kong, Hong Kong
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy